Menu
Agenda
Wednesday, October 18 | ||
|---|---|---|
Pre-Conference:
The Role of Digital Health & Technology in Cardiometabolic Risk Reduction: Where We Are and Where Are We Going | ||
11:30 AM — 11:35 AM | Opening Remarks Chair: Seth Martin, MD, MHS | |
11:35 AM — 11:55 AM | Setting the Stage: What Digital Health Means for Clinicians and Patients Patrick Dunn, PhD | |
Technology & Digital Health in Lifestyle and Obesity | ||
11:55 AM – 12:15 PM | Health and Care Apps for Lifestyle and Obesity: The Importance of Self-Monitoring Tiffany Powell-Wiley, MD, MPH | |
12:15 PM – 12:35 PM | Continuous Glucose Monitoring: The New Frontier in Lifestyle Management? Athena Philis-Tsimikas, MD | |
12:35 PM – 12:55 PM | Changing Behavior Using Digital Health for Long Term Weight Management Martin S. Hagger, PhD | |
12:55 PM – 1:05 PM | Panel Discussion and Audience Q&A Moderator: Seth Martin, MD, MHS Panelists: Tiffany Powell-Wiley, MD, MPH; Athena Philis-Tsimikas, MD; Martin S. Hagger, PhD | |
Technology & Digital Health in Type 2 Diabetes | ||
1:05 PM – 1:20 PM | Refresh and Recharge Break | |
1:20 PM – 1:50 PM | The Role of CGM in the Management of Type 2 Diabetes: Patient Selection & Important Pearls Supported by Dexcom. Grazia Aleppo, MD, FACE, FACP | |
1:50 PM – 2:10 PM | Insulin Delivery and Insulin Pumps in Patients with Type 2 Diabetes Viral S. Shah, MD | |
2:10 PM – 2:20 PM | Panel Discussion and Audience Q&A Moderator: Seth Martin, MD, MHS Panelists: Grazia Aleppo, MD, FACE, FACP; Viral Shah, MD | |
Technology & Digital Health in CVD & CVD Risk Reduction | ||
2:20 PM – 2:40 PM | Technology to Close Gaps in Hypertension Care Daichi Shimbo, MD | |
2:40 PM – 3:00 PM | Advances in Digital Health for Arrhythmia Management Mohamed B. Elshazly, MD, MBEE, FACC | |
3:00 PM – 3:20 PM | Health Technologies for CVD Prevention Francoise Marvel, MD | |
3:20 PM – 3:30 PM | Panel Discussion and Audience Q&A Moderator: Seth Martin, MD, MHS Panelists: Daichi Shimbo, MD; Mohamed B. Elshazly, MD, MBEE, FACC: Francoise Marvel, MD | |
Technology & Digital Health in Cardiometabolic Health: Discussions & Practical Strategies for Implementation | ||
3:30 PM – 3:45 PM | Refresh and Recharge Break | |
3:45 PM – 4:15 PM | Discussions & Perspectives: What Role Does Technology and Digital Health Play in Addressing Disparities in Care? Moderator: Seth Martin, MD, MHS Panelists: Yvonne Commodore-Mensah, PhD, MHS, RN; Christie M. Ballantyne, MD | |
4:15 PM – 4:45 PM | How Do Clinicians and Patients Better Use This Data: Challenges and Possible Solutions Moderator: Seth Martin, MD, MHS Panelists: Francoise Marvel, MD; Eric D. Peterson, MD, MPH | |
4:45 PM – 5:15 PM | Fireside Chat Reception Light bites and drinks will be served. | |
5:15 PM – 6:30 PM | Fireside Chat (Non-CME) Insights from Industry – Next Frontiers in Digital Interventions to Improve Cardiometabolic Health Moderator: Seth Martin, MD, MHS Panelists: Patrick Dunn, PhD; Grant Groves, PhD; Stephen Lynch; Francoise Marvel, MD; Kapil Parakh, MD, MPH, PhD | |
6:30 PM – 7:00 PM | Fireside Connect Mix and mingle with industry experts and colleagues following the Fireside Chat. | |
Thursday, October 19 | ||
|---|---|---|
FDA Updates and Keynote | ||
7:00 AM – 7:45 AM | PME Breakfast Symposium (non-CME) A Treatment Option for Patients with Heart Failure Sponsored by AstraZeneca. Surendra Sivarajah, MD; Justin Fongemie, PharmD | |
7:45 AM – 8:15 AM | Refresh and Recharge Break | |
8:15 AM – 10:15 AM | Opening Remarks & FDA Update and Late Breaking Trials Moderator: Christie M. Ballantyne, MD Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand; Anne L. Peters, MD | |
10:15 AM – 10:45 AM | Keynote Address Screening for Social Determinants of Cardiometabolic Health & Practice Implications A. Enrique Caballero, MD | |
10:45 AM – 11:15 AM | Exhibit Hall Break | |
11:15 AM – 12:15 PM | PME Lunch Symposium (non-CME) Explore This GLP-1 RA For Your Patients With T2D and Established Sponsored by Novo Nordisk Matthew Budoff, MD, FACC, FAHA | |
Session I: Obesity & Lifestyle | ||
12:15 PM – 12:45 PM | Exhibit Hall Break | |
12:45 PM – 12:45 PM | Opening Remarks Robert H. Eckel, MD | |
12:45 PM– 1:45 PM | Diving Deeper Into Exercise Regimens for Cardiometabolic Health Mercedes Carnethon, PhD; Jane Reusch, MD | |
1:45 PM– 2:45 PM | Debate and Discussion: Is it Time to Compare High-Intensity Pharmacotherapy to Surgery for the Management of Obesity? Donna H. Ryan, MD; Christopher D. Still, DO | |
2:45 PM – 3:15 PM | Exhibit Hall Break | |
3:15 PM – 3:35 PM | The Intersection of Sleep and Cardiometabolic Risk: Important Connections and Practice Implications Sirimon Reutrakul, MD | |
3:35 PM – 4:35 PM | Primetime CME Symposium The Intersection of NASH and Cardiometabolic Risk: Applying Advances in Diagnosis and Management To Tackle The NASH Epidemic Supported by an educational grant from Novo Nordisk. Chair: Robert H. Eckel, MD Faculty: Diana Barb, MD; Amreen Dinani, MD, MSc | |
4:35 PM – 5:30 PM | Challenging Obesity Cases & Panel Discussion Moderator: Robert H. Eckel, MD Panelists: Mercedes Carnethon, PhD; Jane Reusch, MD; Donna H. Ryan, MD; Sirimon Reutrakul, MD; Christopher D. Still, DO | |
5:30 PM – 6:30 PM | Welcome Reception | |
6:30 PM – 7:30 PM | Dinner Symposium (Non-CME) Discover EVKEEZA Sponsored by Regeneron Pharmaceuticals Matthew Budoff, MD, FACC, FAHA followed by an EVKEEZA patient | |
Friday, October 20 | 7:00 AM – 8:00 AM | CME Breakfast Symposium Understanding the Role of Lp(a) as a CV Risk Marker to Therapeutic Target in the Prevention of ASCVD Supported by an educational grant from Novartis Pharmaceuticals Corporation. Chair: Patrick M. Moriarty, MD Faculty: Christie M. Ballantyne, MD; Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC |
|---|---|---|
Session II: Dyslipidemia/Atherosclerosis/Thrombosis | ||
8:00 AM – 8:05 AM | Opening Remarks Christie M. Ballantyne, MD | |
8:05 AM – 8:25 AM | Colchicine for Chronic Atherosclerosis as an Adjunct to Statin Therapy Paul Ridker, MD | |
8:25 AM – 8:45 AM | Statin Intolerance: How To Assess and Practical Pearls for Addressing It Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC | |
8:45 AM – 9:05 AM | Hypertriglyceridemia: Trials, Tribulations, and Transition to Clinical Practice Michael D. Shapiro, DO | |
9:05 AM – 10:25 AM | Primetime CME Symposium Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift Supported by an educational grant from Novartis Pharmaceuticals Corporation. Chair: Christie M. Ballantyne, MD Faculty: Pamela B. Morris, MD; Pam R. Taub, MD, FACC, FASPC | |
10:25 AM – 11:25 AM | Challenging Lipid Management Cases & Panel Discussion Moderator: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD, Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC; Pamela B. Morris, MD; Paul Ridker, MD; Michael D. Shapiro, DO | |
11:25 AM – 11:55 AM | Exhibit Hall Break | |
11:55 AM – 12:55 PM | PME Lunch Symposium (non-CME) Identifying and Discussing the Unmet Needs in the Management of Severe Hypertriglyceridemia Sponsored by Ionis Pharmaceuticals, Inc. Michael D. Shapiro, MD | |
12:55 PM – 1:25 PM | Exhibit Hall Break | |
Session III: Diabetes | ||
1:25 PM – 1:25 PM | Opening Remarks Anne L. Peters, MD | |
1:25 PM – 1:45 PM | Where Are We With Respect to Glycemic Control in T2D? A 2023 Update Vanita R. Aroda, MD | |
1:45 PM – 2:10 PM | Early Treatment Intensification in Type 2 Diabetes Juan P. Frias, MD | |
2:10 PM – 3:10 PM | Heterogeneity of Diabetes & Panel Discussion Anne L. Peters, MD | |
3:10 PM – 3:40 PM | Exhibit Hall Break | |
3:40 PM – 4:00 PM | Optimizing Glycemic Control With Commonly-Available Combination Therapies: Tips and Pearls Athena Philis-Tsimikas, MD | |
4:00 PM – 4:20 PM | How Social Determinants of Health Impact Type 2 Diabetes Treatment Shivani Agarwal, MD, MPH | |
4:20 PM – 5:20 PM | Challenging Diabetes Management Cases & Panel Discussion Moderator: Anne L. Peters, MD Panelists: Shivani Agarwal, MD, MPH; Vanita R. Aroda, MD; Juan P. Frias, MD; Athena Philis-Tsimikas, MD | |
5:20 PM – 6:30 PM | Happy Hour & Giveaways | |
Saturday, October 21 | ||
|---|---|---|
Session IV: CardioRenal | ||
7:00 AM – 8:00 AM | PME Breakfast Symposium (non-CME) Cycloset Reduced CVD Outcomes Within 1 year in T2D Subjects: Identified Contributory Mechanisms – Published Study Results Sponsored by VeroScience. Anthony H. Cincotta, PhD | |
8:00 AM – 8:30 AM | Refresh and Recharge Break | |
8:30 AM – 8:30 AM | Opening Remarks Keith C. Ferdinand, MD | |
8:30 AM – 9:35 AM | Tackling the Disproportionate Burden of Resistant Hypertension in Black Adults: Perspectives & Advances • Overcoming Barriers to Hypertension Control and Cardiovascular Disease: We Need to Do Better • Resistant Hypertension: Definitions, Current Treatment and Emerging Approaches Supported by an independent medical educational grant from Medtronic. Keith C. Ferdinand, MD; Debbie Cohen, MD | |
9:35 AM – 10:05 AM | Sleep and Hypertension: A Two-Way Street Virend K. Somers, MD, PhD | |
10:05 AM – 10:35 AM | The Role of Steroidal and Non-steroidal MRAs in Cardiorenal Risk Reduction Ajay K. Singh, MBBS, FRCP, MBA | |
10:35 AM – 10:50 AM | Refresh and Recharge Break | |
10:50 AM – 11:10 AM | Which Patients Should Get SGLT2is and GLP-1 RAs for cardiorenal risk reduction? Interpreting Guidelines and Clinical Trials to Patient Care Pam R. Taub, MD, FACC, FASPC | |
11:10 AM – 11:30 PM | The Continuum of Heart Failure Alanna A. Morris MD, MSc, FHFSA, FACC, FAHA | |
11:30 PM – 12:30 PM | Challenging Cardiorenal Cases & Expert Panel Discussion Moderator: Keith C. Ferdinand, MD Panelists: Debbie Cohen, MD; Alanna Morris MD, MSc, FHFSA, FACC, FAHA; Ajay K. Singh, MBBS, FRCP, MBA; Virend K. Somers, MD, PhD; Pam R. Taub, MD, FACC, FASPC | |
